🧪 Anti-Diphtheria Antibody (EIA)

ByCDL.MD.phD.

1. Overview of Anti-Diphtheria Antibody Test

The Anti-Diphtheria Antibody (Diphtheria Toxin Antibody) test evaluates immunity against diphtheria, usually acquired through DTaP/Tdap vaccination.

Key points:

  • Diphtheria is caused by Corynebacterium diphtheriae producing a potent toxin
  • Antibody levels reflect vaccine-induced immunity rather than active infection
  • Monitored by WHO to guide immunization programs and high-risk population protection

2. Test Purpose

  1. Evaluate immunity to diphtheria
    • Verify antitoxin formation after DTaP/Tdap vaccination
    • Assess vaccination needs for children, adults, and pregnant women
  2. Check protection in immunocompromised individuals
    • Organ transplant recipients
    • Cancer patients undergoing chemotherapy
    • Primary immunodeficiency patients
  3. Assess laboratory or clinical risk groups
    • Healthcare workers
    • Travelers to endemic regions

⚠ Note: This is not a diagnostic test for acute infection. PCR, culture, or Elek toxin assay required for confirmed diphtheria diagnosis.

3. Specimen and Test Method (EIA)

Specimen

  • Serum

Test Method: Enzyme Immunoassay (EIA)

  1. Wells coated with diphtheria toxin antigen
  2. Patient serum added → binds to antigen if antibodies present
  3. Enzyme-labeled secondary antibody binds → substrate added
  4. Colorimetric reaction measured → optical density (OD)
  5. Antibody concentration calculated in IU/mL

Advantages of EIA

  • High reproducibility
  • Quantitative
  • Internationally standardized

4. Reference Ranges (WHO & Manufacturer Guidelines)

Antibody Level (IU/mL)Interpretation
< 0.01No protection
0.01 – 0.09Basic/partial protection → booster recommended
0.1 – 0.9Protective immunity
≥ 1.0Long-term protection

Note: Values may vary slightly by manufacturer.

5. Clinical Significance

  • Verify post-vaccine immunity
    • Confirms adequate response to DTaP/Tdap
  • Booster recommendation for immunocompromised or adults
    • Low antibody levels → consider additional vaccination
  • Natural antibody decline over time
    • Adults may require Tdap booster
  • Not for acute infection diagnosis
    • Antibody levels alone do not indicate current infection

6. Factors Affecting Antibody Levels

High Levels

  • Recent DTaP/Tdap vaccination
  • Recovery from natural infection
  • Recent booster dose

Low Levels

  • Long interval since last vaccination
  • Older age
  • Immunocompromised conditions (chemotherapy, steroids, primary immunodeficiency)
  • Poor nutritional status

7. Interpretation Considerations

  1. Not a diagnostic test → antibody presence ≠ active infection
  2. Antibody wanes over time → immune status may change
  3. EIA results alone may not reflect vaccination history → verify records
  4. High antibody levels may still require booster in high-risk populations (e.g., healthcare workers)
  5. Prior IVIG therapy can artificially raise antibody levels

8. Summary Table

ItemKey Points
Test NameAnti-Diphtheria Antibody (EIA)
SpecimenSerum
PrincipleAntigen-antibody binding with enzyme colorimetric detection
Reference Ranges<0.01 IU/mL None / 0.01–0.09 Basic / 0.1–0.9 Protective / ≥1.0 Long-term
Clinical UsePost-vaccine immunity assessment, booster recommendations, immunocompromised monitoring
LimitationsNot for acute infection diagnosis; results must be interpreted with vaccination history and clinical context

9. References

  • WHO. Diphtheria vaccine: Immunological basis of vaccination
  • Galazka A, et al. “Diphtheria: Clinical and laboratory aspects.” Journal of Infectious Diseases
  • Efstratiou A & George RC. “Laboratory diagnosis of diphtheria.” Journal of Medical Microbiology
  • CDC. Diphtheria: Prevention and Control Guidelines

🧪 Anti-Diphtheria Antibody (EIA) — Complete Guide

Meta Title (SEO)

Anti-Diphtheria Antibody EIA Test — Immunity Assessment, Reference Ranges & Clinical Interpretation

Meta Description (SEO)

Comprehensive guide to Anti-Diphtheria Antibody testing using EIA. Learn test principles, specimen requirements, reference ranges, clinical significance, and interpretation for vaccination and immunity evaluation.

SEO Keywords

Anti-Diphtheria antibody, EIA test, diphtheria immunity, DTaP Tdap, antibody levels, vaccine evaluation, serological testing, diphtheria protection, booster assessment, immunocompromised patient

1. Overview of Anti-Diphtheria Antibody Test

The Anti-Diphtheria Antibody (Diphtheria Toxin Antibody) test evaluates immunity against diphtheria, usually acquired through DTaP/Tdap vaccination.

Key points:

  • Diphtheria is caused by Corynebacterium diphtheriae producing a potent toxin
  • Antibody levels reflect vaccine-induced immunity rather than active infection
  • Monitored by WHO to guide immunization programs and high-risk population protection

2. Test Purpose

  1. Evaluate immunity to diphtheria
    • Verify antitoxin formation after DTaP/Tdap vaccination
    • Assess vaccination needs for children, adults, and pregnant women
  2. Check protection in immunocompromised individuals
    • Organ transplant recipients
    • Cancer patients undergoing chemotherapy
    • Primary immunodeficiency patients
  3. Assess laboratory or clinical risk groups
    • Healthcare workers
    • Travelers to endemic regions

⚠ Note: This is not a diagnostic test for acute infection. PCR, culture, or Elek toxin assay required for confirmed diphtheria diagnosis.

3. Specimen and Test Method (EIA)

Specimen

  • Serum

Test Method: Enzyme Immunoassay (EIA)

  1. Wells coated with diphtheria toxin antigen
  2. Patient serum added → binds to antigen if antibodies present
  3. Enzyme-labeled secondary antibody binds → substrate added
  4. Colorimetric reaction measured → optical density (OD)
  5. Antibody concentration calculated in IU/mL

Advantages of EIA

  • High reproducibility
  • Quantitative
  • Internationally standardized

4. Reference Ranges (WHO & Manufacturer Guidelines)

Antibody Level (IU/mL)Interpretation
< 0.01No protection
0.01 – 0.09Basic/partial protection → booster recommended
0.1 – 0.9Protective immunity
≥ 1.0Long-term protection

Note: Values may vary slightly by manufacturer.

5. Clinical Significance

  • Verify post-vaccine immunity
    • Confirms adequate response to DTaP/Tdap
  • Booster recommendation for immunocompromised or adults
    • Low antibody levels → consider additional vaccination
  • Natural antibody decline over time
    • Adults may require Tdap booster
  • Not for acute infection diagnosis
    • Antibody levels alone do not indicate current infection

6. Factors Affecting Antibody Levels

High Levels

  • Recent DTaP/Tdap vaccination
  • Recovery from natural infection
  • Recent booster dose

Low Levels

  • Long interval since last vaccination
  • Older age
  • Immunocompromised conditions (chemotherapy, steroids, primary immunodeficiency)
  • Poor nutritional status

7. Interpretation Considerations

  1. Not a diagnostic test → antibody presence ≠ active infection
  2. Antibody wanes over time → immune status may change
  3. EIA results alone may not reflect vaccination history → verify records
  4. High antibody levels may still require booster in high-risk populations (e.g., healthcare workers)
  5. Prior IVIG therapy can artificially raise antibody levels

8. Summary Table

ItemKey Points
Test NameAnti-Diphtheria Antibody (EIA)
SpecimenSerum
PrincipleAntigen-antibody binding with enzyme colorimetric detection
Reference Ranges<0.01 IU/mL None / 0.01–0.09 Basic / 0.1–0.9 Protective / ≥1.0 Long-term
Clinical UsePost-vaccine immunity assessment, booster recommendations, immunocompromised monitoring
LimitationsNot for acute infection diagnosis; results must be interpreted with vaccination history and clinical context

9. References

  • WHO. Diphtheria vaccine: Immunological basis of vaccination
  • Galazka A, et al. “Diphtheria: Clinical and laboratory aspects.” Journal of Infectious Diseases
  • Efstratiou A & George RC. “Laboratory diagnosis of diphtheria.” Journal of Medical Microbiology
  • CDC. Diphtheria: Prevention and Control Guidelines

Similar Posts

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 필드는 *로 표시됩니다